Insight Briefs18 September 2025 ICH GCP E6(R3) Implementation: Practical Approaches and Real-World Considerations ICH GCP E6(R3) implementation requires strategic planning beyond basic compliance. This practical guide covers realistic 12-18 month timelines,... Learn more
Insight Briefs16 September 2025 Decentralized Clinical Trial Platforms in 2025: A Practical Guide for Clinical Operations DCT platform evaluation guide: integration strategies, vendor comparison, implementation timelines for clinical operations teams. Learn more
Demos9 September 2025 On-site ePRO Castor’s On-site ePRO ensures higher flexibility for both study designers and participants, by maximizing opportunities for data capture. Learn more
Factsheets9 September 2025 Castor On-site ePRO Download our On-site ePRO factsheet to view an overview of our services. Learn more
Blog26 August 2025 EQ-5D in European Trials: When Generic QoL Measures Actually Matter Analysis of 735 FDA drug approvals reveals 0% EQ-5D labeling inclusion, while European HTA bodies demonstrate 18% technology... Learn more
Webinar Castor Product Spotlight: New On-site ePRO Watch this on-demand Product Spotlight to see Castor’s On-site ePRO in action. Our experts show how on-site capture... Learn more
Insight Briefs14 August 2025 Navigating the eCOA Vendor Landscape in 2025: What Clinical Teams Really Need to Know The eCOA market reached $2.27 billion in 2025 with 16.1% projected growth, yet vendor selection remains critical for... Learn more
Insight Briefs7 August 2025 Optimizing eCOA in Oncology Trials: Patient-Focused Data Capture for Cancer Research Oncology leads clinical innovation with 7,747 trials registered through 2022, yet only 7% of cancer patients participate. This... Learn more
Blog31 July 2025 ePRO, eCOA 101: Everything You Need to Know About ePRO and eCOA Electronic Clinical Outcome Assessment (ECOA) and electronic Patient Reported Outcomes (ePRO) represent far more than digital surveys in... Learn more
Blog18 July 2025 Why eCOA Still Fails in Clinical Trials: Practical Strategies to Fix Baseline Data Problems Electronic clinical outcome assessments (eCOA) were supposed to solve data quality and amplify the patient voice. Yet missing... Learn more
Blog26 June 2025 How a 3-Person Team Got to Phase 3 — Without the Overhead Gameto proves you don’t need a large CRO or a floor of data managers to run complex global... Learn more
Blog26 June 2025 From Hype to Health: What Sword Health Got Right About Evidence Sword Health didn’t follow the typical digital health playbook. Instead of rushing to market, they invested early in... Learn more
Webinar Broken at Baseline: Why eCOA Fails in the Real World (and Why We Don’t Talk About It) Why are baseline PROs still going uncaptured in 2025? Join Ari Gnanasakthy, Katja Rudell & Derk Arts to... Learn more
News5 June 2025 Castor Bolsters Remote Study Engagement with Streamlined Participant Workflow OTP login is now standard in Castor’s eConsent platform. No account setup or passwords to create. Participants receive... Learn more
Blog28 May 2025 The New Standard in Participant-Centric Trials: What Castor’s 2025 Updates Reveal About the Future of Clinical Research Explore how Castor’s 2025 updates reduce site burden and boost compliance through scalable, flexible DTP workflows. Learn more
Blog28 May 2025 Building Biotech: From Science to Scale – Strategic Lessons from the Frontline Hard truths on scaling biotech: data isn’t enough, CEOs matter, and funding follows story—not science. Learn more
Webinar From Hype to Health: How Sword Built Evidence That Scales How Sword Health used long-term clinical validation to scale, prove outcomes, and build real credibility in digital MSK... Learn more
Success Stories19 May 2025 Oncobiomix: Slashing Costs and Elevating Data Quality Discover how Oncobiomix used an integrated platform for eConsent, EDC, and ePRO to save $100K and streamline data... Learn more
